Global Rise of Compounded Weight-Loss Medicines: A Worrisome Trend
The rise of compounded weight-loss drugs has emerged as a pressing global health issue, threatening consumers and health-care systems. Factors fueling this crisis include the desire for rapid weight-loss options, inadequate regulatory frameworks, and the easy availability of compounded products through online platforms and social media. Vulnerable populations, particularly those searching for low-cost treatments, are hit hardest. Tackling this escalating problem calls for a comprehensive strategy: enhancing regulatory oversight, raising public awareness, and fostering stakeholder collaboration. We can reduce the health dangers of compounded weight-loss medications by addressing the underlying causes and improving consumer safety. This article examines the risks associated with compounded weight-loss drugs and suggests practical measures to protect public health.
Authors
- Rohini Garg (ORCID: https://orcid.org/0000-0002-6167-1460)
- Nikhil Sood (ORCID: https://orcid.org/0009-0007-9456-5828)
Institutions
- Banner Health (US)
- CHI Health Mercy Council Bluffs (US)
Publication Details
- Journal
- Journal of the Endocrine Society
- Published
- 2025-06-07
- DOI
- https://doi.org/10.1210/jendso/bvaf084
- Citations
- 1
- Primary Topic
- Pharmacology and Obesity Treatment
- Type
- article
- Field-Weighted Citation Impact
- 1.39